ICYMI: Research Roundup from CROI 2023
Last month, HIV.gov had the opportunity to speak with our colleagues from NIH, CDC, and HRSA and with community members about the latest research on HIV and related issues presented at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, WA. Here’s a roundup of key topics covered in our blog posts and video conversations so you can catch up on any of that you may have missed and share them with your friends and colleagues:
To learn about:
- Long-acting HIV treatment for people with HIV who were not previously virally suppressed and with co-occurring mental health or substance use disorders, or housing instability, check out our conversations with HRSA’s Dr. Laura Cheever, NIH’s Dr. Carl Dieffenbach, and CDC’s Dr. Jonathan Mermin and Dr. John Brooks. Also, read this NIH news release: Long-acting antiretroviral therapy suppresses HIV among people with unstable housing, mental illnesses, substance use disorders.
- Long-acting HIV PrEP, check out our conversation with Yale’s Dr. LaRon Nelson, who focused on addressing PrEP disparities, as well as our conversations with NIH’s Dr. Dieffenbach, and CDC’s Dr. Mermin and Dr. Brooks.
- Cure news, check out this conversation with NIH’s Dr. Dieffenbach.
- HIV vaccine research, check out this conversation with NIH’s Dr. Dieffenbach.
- HIV and women, check out our conversation with SisterLove’s Dazon Dixon Diallo.
- Mpox and its impact on people with HIV, check out our conversation with CDC’s Dr. Mermin and Dr. Brooks.
- New research on STI post-exposure prophylaxis (PEP), check out our conversations with NIH’s Dr. Dieffenbach and CDC’s Dr. Mermin.
- Updated HIV clinical practice guidelines on infant feeding, check out our conversation with HRSA’s Dr. Cheever.
You can also find the videos to view and share on HIV.gov’s Facebook page, TwitterExit Disclaimer, and YouTube, and on the LinkedIn page for the HHS Office of Infectious Disease and HIV/AIDS PolicyExit Disclaimer.